Update on Mental Health Services In Rural Areas
For providing affordable and accessible mental healthcare facilities in the country, the Government is implementing the National Mental Health Programme (NMHP) in the country. The District Mental Health Programme (DMHP) component of the NMHP has been sanctioned for implementation in 738 districts for which support is provided to States/UTs through the National Health Mission. Facilities […]
Norms for fixing Prices of Medicines
As per the extant provisions of DPCO 2013, every manufacturer of a scheduled or non-scheduled formulation intended for sale, shall display in indelible print mark, on the label of container of the formulation and the minimum pack thereof offered for retail sale, the maximum retail price of that formulation with the words "Maximum Retail Price" […]
Disease Outbreak News: Anthrax - Zambia
On 1 November 2023, the International Health Regulations (IHR) National Focal Point of Zambia notified WHO of an anthrax outbreak in humans. The first human cases were reported from the Dengeza Health Post in the Sinazongwe District of the Southern Province on 5 May 2023. Around the same time period, domestic (cattle and goats) and […]
WHO appeals for protection of the health system from further attacks and degradation of its capacity
Once again, nowhere is safe in Gaza. WHO is gravely concerned about the resumption of hostilities, including heavy bombardment in Gaza, and reiterates its appeal to Israel to take every possible measure to protect civilians and civilian infrastructure, including hospitals, as per the laws of war. We have seen what happened in northern Gaza. This […]
Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
Phase III (INAVO120) results show that inavolisib in combination with palbociclib and fulvestrant significantly improved progression-free survival in the first-line setting PIK3CA mutations, found in approximately 40% of HR-positive breast cancers, are linked to tumour growth, disease progression, and treatment resistance Data will be shared with health authorities and presented at an upcoming medical meeting […]
Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection
Elecsys® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active hepatitis in combination with other laboratory results and clinical information. The single test will inform clinicians if treatment is required and regimens are working in conjunction with other […]
WHO leads very high-risk joint humanitarian mission to Al-Shifa Hospital in Gaza
Earlier today, a joint UN humanitarian assessment team, led by WHO accessed Al-Shifa Hospital in northern Gaza to assess the situation on the ground and conduct a rapid situational analysis, assess medical priorities, and establish logistics options for further missions. The team included public health experts, logistics officers, and security staff from OCHA, UNDSS, UNMAS/UNOPS, […]
New WHO campaign highlights tobacco industry tactics to influence public health policies
The World Health Organization (WHO), today, officially launches the "Stop the lies" campaign as a vital initiative to protect young people from the tobacco industry and their deadly products, by calling for an end to tobacco industry interference in health policy. This campaign is supported by new evidence from “The Global Tobacco Industry Interference Index […]
National Health Authority (NHA) organises Accelerator Workshops on ABDM Integration and NHCX Adoption in association with IRDAI
The National Health Authority (NHA) and the Insurance Regulatory and Development Authority of India (IRDAI) have joined hands to operationalize the National Health Claim Exchange (NHCX), a digital health claims platform developed by National Health Authority. This initiative is being undertaken in the context of a circular issued by IRDAI in June 2023, whereby the […]
Roche’s subcutaneous injection of Tecentriq recommended by the EU’s CHMP for multiple cancer types
If approved, Tecentriq subcutaneous (SC) would be the first injectable PD-(L)1 cancer immunotherapy in the EU, cutting treatment time by approx. 80%1 The CHMP recommended Tecentriq SC for all indications of intravenous (IV) Tecentriq, including certain types of lung, liver, bladder and breast cancer2 A majority of healthcare professionals surveyed in the IMscin001 study found […]
